These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 7998063)
1. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components. Dzieczkowski JS; Barrett BB; Nester D; Campbell M; Cook J; Sugrue M; Andersen JW; Anderson KC Transfusion; 1995 Jan; 35(1):20-5. PubMed ID: 7998063 [TBL] [Abstract][Full Text] [Related]
2. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Federowicz I; Barrett BB; Andersen JW; Urashima M; Popovsky MA; Anderson KC Transfusion; 1996 Jan; 36(1):21-8. PubMed ID: 8607149 [TBL] [Abstract][Full Text] [Related]
3. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Yazer MH; Podlosky L; Clarke G; Nahirniak SM Transfusion; 2004 Jan; 44(1):10-5. PubMed ID: 14692961 [TBL] [Abstract][Full Text] [Related]
4. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. King KE; Shirey RS; Thoman SK; Bensen-Kennedy D; Tanz WS; Ness PM Transfusion; 2004 Jan; 44(1):25-9. PubMed ID: 14692963 [TBL] [Abstract][Full Text] [Related]
5. Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital. Rajesh K; Harsh S; Amarjit K Ann Med Health Sci Res; 2015; 5(3):185-8. PubMed ID: 26097760 [TBL] [Abstract][Full Text] [Related]
6. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction. Couban S; Carruthers J; Andreou P; Klama LN; Barr R; Kelton JG; Heddle NM Transfusion; 2002 Jun; 42(6):753-8. PubMed ID: 12147029 [TBL] [Abstract][Full Text] [Related]
7. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Uhlmann EJ; Isgriggs E; Wallhermfechtel M; Goodnough LT Transfusion; 2001 Aug; 41(8):997-1000. PubMed ID: 11493730 [TBL] [Abstract][Full Text] [Related]
8. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial. Oksanen K; Kekomäki R; Ruutu T; Koskimies S; Myllylä G Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788 [TBL] [Abstract][Full Text] [Related]
9. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets. Wang RR; Triulzi DJ; Qu L Am J Clin Pathol; 2012 Aug; 138(2):255-9. PubMed ID: 22904138 [TBL] [Abstract][Full Text] [Related]
10. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions. Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820 [TBL] [Abstract][Full Text] [Related]
12. Impact of buffy coat reduction on the severity of febrile nonhemolytic transfusion reactions with red cell components. Singh L; Prinja N; Jain A; Sharma RR; Marwaha N Asian J Transfus Sci; 2023; 17(1):69-73. PubMed ID: 37188007 [TBL] [Abstract][Full Text] [Related]
13. Feeling the burn: the significant burden of febrile nonhemolytic transfusion reactions. Cohen R; Escorcia A; Tasmin F; Lima A; Lin Y; Lieberman L; Pendergrast J; Callum J; Cserti-Gazdewich C Transfusion; 2017 Jul; 57(7):1674-1683. PubMed ID: 28369916 [TBL] [Abstract][Full Text] [Related]
14. Human leucocyte antigen alloimmunisation in repeatedly transfused thalassemic Egyptian children and its relation to febrile non-haemolytic transfusion reactions. Mourad Z; Hassab H; Younan D; Abdo A Transfus Med; 2015 Dec; 25(6):380-4. PubMed ID: 26578338 [TBL] [Abstract][Full Text] [Related]
15. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Paglino JC; Pomper GJ; Fisch GS; Champion MH; Snyder EL Transfusion; 2004 Jan; 44(1):16-24. PubMed ID: 14692962 [TBL] [Abstract][Full Text] [Related]
16. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Klüter H; Bubel S; Kirchner H; Wilhelm D Transfusion; 1999; 39(11-12):1179-84. PubMed ID: 10604243 [TBL] [Abstract][Full Text] [Related]
17. Leukocyte reduction in blood component therapy. Lane TA; Anderson KC; Goodnough LT; Kurtz S; Moroff G; Pisciotto PT; Sayers M; Silberstein LE Ann Intern Med; 1992 Jul; 117(2):151-62. PubMed ID: 1605430 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of 516 reports of reactions after the transfusion of labile blood products]. Frère MC; Rapaille A; Bouillenne C; Gérard C; Sondag D; Verhees A Transfus Clin Biol; 2001 Aug; 8(4):333-42. PubMed ID: 11642025 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of WBC reduction in neonates: what is the evidence of benefit? Fergusson D; Hébert PC; Barrington KJ; Shapiro SH Transfusion; 2002 Feb; 42(2):159-65. PubMed ID: 11896329 [TBL] [Abstract][Full Text] [Related]
20. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets. Eder AF; Dy BA; O'Neill EM Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]